School of Medicine
Showing 451-500 of 755 Results
-
Amanda Kirane, MD, PhD, FACS, FSSO
Assistant Professor of Surgery (General Surgery)
BioDr. Kirane is a fellowship-trained, board-certified specialist in complex general surgical oncology. She is an Assistant Professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine. Dr. Kirane serves as Director of Cutaneous Surgical Oncology at the Stanford Cancer Center and her clinical practice focuses on the diagnosis and treatment of melanoma and other skin cancers. She partners closely with patients and families to provide the most effective treatment approach possible. For each patient, she tailors an evidence-based, personalized care plan that is innovative, comprehensive, and compassionate.
Dr. Kirane is Principal Investigator of multiple studies in melanoma and mechanisms of resistance to immunotherapy, with focus on myeloid biology. Her current interests include immune response and novel therapies in melanoma, predictive modeling of patient responses using organoid technology, and translational biomarker development. She has led research into immune therapy for earlier stage melanoma using regionally directed therapy to augment immune response in melanoma and trials in surgical care in melanoma.
The National Institutes of Health, American Society of Clinical Oncology, the Melanoma Research Alliance, and others have funded her research. She has co-authored articles on her discoveries in the Journal of Clinical Investigation, Nature Communications, Nature Genetics, Cancer Research, Journal of Surgical Oncology, Annals of Surgery, Annals of Surgical Oncology, and elsewhere. Topics include intratumoral therapy, biomarker development, macrophage biology in melanoma and immunotheraputic resistance, and patient-derived organoid modeling. Dr. Kirane has presented updates on the management of melanoma and other cancers to her peers at meetings of the American College of Surgeons, Society of Surgical Oncology, and Society for Immunotherapy in Cancer.
Dr. Kirane has earned awards for her achievements in clinical care, research, and scholarship. The Society for Immunotherapy of Cancer, Society of Surgical Oncology, Memorial Sloan Kettering Cancer Center, and other prestigious organizations have honored her work. She is a fellow of the American College of Surgeons (FACS) and Society of Surgical Oncology (FSSO). She is a member of the Society for Immunotherapy of Cancer, American Association of Cancer Research, Society for Melanoma Research, Connective Tissue Oncology Society, Association of Academic Surgeons, and Association of Women Surgeons.
She volunteers her time and expertise on behalf of the Melanoma Research Foundation, members of her community in need, STEM programs for girls, and other initiatives. She also is fellowship trained in Physician Wellness and Wellbeing and teaches somatic technique, mindfulness-based stress reduction, meditation, and breathwork. -
Varvara A. Kirchner
Associate Professor of Surgery (Abdominal Transplantation) and, by courtesy, of Pediatrics
BioDr. Kirchner completed her medical school, surgical residency and multi-organ transplant fellowship in adult and pediatric liver, pancreas, kidney transplantation and total pancreatectomy with islet auto-transplantation at the University of Minnesota. She underwent further training in living donor liver transplantation and hepatobiliary surgery at the Asan Medical Center, Seoul, South Korea. Her clinical practice involves living and deceased donor liver and kidney transplantation in adult and pediatric patients as well as total pancreatectomy with islet auto-transplantation for patients with chronic and acute recurrent pancreatitis. She currently serves as Surgical Director of the Islet Cell Auto-Transplant at Stanford Children’s and Associate Director of the Living Donor Liver Transplant Program at the Division of Abdominal Transplantation. Dr. Kirchner’s research focuses on the biology of aging, cellular and solid organ transplantation. Her specific interests are in auto-islet transplantation, iPSC-derived hepatocyte therapies and liver regeneration. Dr. Kirchner's research on the impact of donor age on generation of iPSC-derived hepatocyte-like cells is supported by the NIA K08 Faculty Development Award. She is an active member of the American Society of Transplant Surgeons and the International Liver Transplantation Society.
-
Karla Kirkegaard
Violetta L. Horton Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe biochemistry of RNA-dependent RNA polymerase function, the cell biology of the membrane rearrangements induced by positive-strand RNA virus infection of human cells, and the genetics of RNA viruses, which, with their high error rates, live at the brink of error catastrophe, are investigated in the Kirkegaard laboratory.
-
Nadia Kirmani
MD Student with Scholarly Concentration in Clinical Research / Immunology, expected graduation Spring 2027
BioBS in Biology & BA in English, Duke University (2019)
Honors: Summa Cum Laude, Phi Beta Kappa
Nadia's research interests include targeted cancer therapeutic development and health equity. -
Hannah Louise Kirsch, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioHannah Louise Kirsch, MD is a board-certified neurologist and a Clinical Assistant Professor in the Neurocritical Care Division of the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Kirsch is also a hospitalist who pays special attention to delivering Stanford Health Care patients the best possible neurological care.
She serves on the National Institute of Neurological Disorders and Stroke committee dedicated to coma and conditions related to consciousness. She has implemented numerous neurology-centered educational activities for health care professionals from diverse specialties, including training psychiatrists on the neuropsychiatric complications of COVID-19. She also has helped educate oncologists and hematologists regarding common neurological conditions among cancer patients.
Dr. Kirsch has conducted research on a range of topics, including thrombotic complications in critically ill COVID-19 patients, advances in intracranial pressure monitoring, and predictors of outcomes in acute encephalitis. She has published her findings in Neurology, the Journal of Trauma, Emergency Medicine, and Procedures, among other journals.
She has given presentations on topics including variations in coagulation among patients with cerebral hemorrhage and the association of cerebral pressure with cardiac arrest. She has shared her discoveries at meetings of the Neurocritical Care Society and Society of Hospital Medicine.
The Neurocritical Care Society has honored her work. She also won the prestigious Leonard Tow Humanism in Medicine Award, which recognizes clinical excellence, outstanding compassion in the delivery of care, and respect for patients, families, and health care colleagues.
Dr. Kirsch received her medical degree from New York University. She completed her residency in neurology at the University of California, San Francisco, and a fellowship in neurocritical care at Columbia University. She also completed the Columbia University narrative medicine certificate program and is board certified in neurology by the American Board of Psychiatry and Neurology. -
Derek M. Klarin, MD
Assistant Professor of Surgery (Vascular Surgery)
On Leave from 06/01/2024 To 05/31/2025BioDr. Klarin is a fellowship-trained vascular surgeon.
For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to help each patient achieve the best possible health and quality of life.
Dr. Klarin performs the full spectrum of diagnostic and treatment procedures for cardiovascular conditions. He treats carotid disease, peripheral artery disease, abdominal aortic aneurysm, venous thromboembolism, and other vascular diseases.
To help advance his field, Dr. Klarin has conducted research. The American Heart Association, Howard Hughes Medical Institute, and other organizations have provided grants to support his studies. He also has co-patented advances in predicting and scoring risk factors for cardiovascular disease and other conditions.
He has published extensively and co-authored more than 50 articles on new techniques and technology for diagnosing and treating cardiovascular disorders. His work has appeared in the Journal of Vascular Surgery, Circulation, JAMA, Nature Medicine, and other peer-reviewed journals.
He also has made many invited presentations to his peers. He has spoken at the Vascular Research Initiatives Conference presented by the Society for Vascular Surgery, the American Heart Association Scientific Sessions, and the annual meeting of the American Society for Human Genetics. Topics include risk factors for peripheral artery disease, the benefits of ultrasound screening for abdominal aortic aneurysm, and the impact of genetic variations on cardiovascular disease.
He is a member of the Global Lipids Genetics Consortium. He is a founding member of the Abdominal Aortic Aneurysm Genetics Consortium and the Peripheral Artery Disease Genetics Consortium. He is also a candidate member of the Society for Vascular Surgery. -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioDr. Jeff Kleck
Current Roles
Adjunct Professor, Stanford University School of Medicine — Stanford, California
Senior Partner, Eleven of Ten (Elevens) — Menlo Park, California
Chairman, Open Power & Energy Network (OPEN) — Menlo Park, California
Senior Advisor, United States Department of Defense (US DoD) — Pentagon, Arlington, Virginia
Previous Academic Appointments
Dean of Academics, Catholic Institute of Technology (CIT) — Cambridge, Massachusetts & Castel Gandolfo, Italy
Adjunct Associate Professor, University of California, Los Angeles (UCLA)
Visiting Scientist, Lawrence Berkeley National Laboratory (LBNL)
Visiting Scientist, Los Alamos National Laboratory (LANL)
Previous Commercial Technology Ventures
President and Board Member, Rapid AI
Founder, CEO, and Chairman of the Board, Attainia
Founder, CEO, and Chairman of the Board, Neoforma
Previous Government Service
Director, Defense Innovation Unit (DIU), United States Department of Defense (US DoD)
Education
Ph.D., Biomedical Physics, University of California, Los Angeles (UCLA)
M.S., Engineering Management, Stanford University, Stanford
M.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
B.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
St. John's University, Collegeville (SJU)
The University of Texas, Austin (UT)
Awards in Current Roles
Ukraine Foreign Military Medal, bestowed by the Commander of the Ukraine Armed Forces (2023)
U.S. Department of Defense Award for Team Cyber & IT Excellence, bestowed by the Chief Information Officer (2019) -
John Kleimeyer, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Kleimeyer specializes in orthopaedic spine surgery, treating cervical, thoracic and lumbar spine disorders including disc herniations, stenosis, myelopathy, fractures, scoliosis and more. He treats both simple and complex spine problems including revisions. His goal is to provide the most minimally invasive solution to improve patients’ quality of life. This includes less invasive discectomies, decompressions, disc replacements, and fusions. He is particularly focused on single-position procedures to limit surgical time and recovery.
Prior to coming to the Stanford Department of Orthopaedic Surgery and the Stanford Spine Center, Dr. Kleimeyer completed his residency in orthopaedic surgery at Stanford University where he was elected to the Alpha Omega Alpha honor society. He then completed his spine fellowship at the renowned Emory University Spine Center. He is board-certified.
Dr. Kleimeyer has received honors and recognition for his research in the fields of orthopaedic surgery and spine surgery. He participates in national and international specialty societies and as a journal reviewer. His research interests include improving clinical outcomes of surgical and nonsurgical care, the genetics of orthopaedic and spine disorders, and cost efficacy. Dr. Kleimeyer has published over 20 journal articles in addition to other reviews and textbook chapters, and has presented research nationally and internationally. -
Jonathan D Klein
Marron and Mary Elizabeth Kendrick Professor of Pediatrics
Current Research and Scholarly InterestsMy studies address:
1. Confidentiality and Access to Care studies of confidential time during well-visits and policy analyses addressing quality of care and health systems capacity for adolescents and young adults in the US and globally; and,
2, Tobacco, nicotine, and second-hand smoke studies of primary care counseling to reduce nicotine addiction in adolescents and programs to engage medical specialty groups in secondhand smoke clinical and policy interventions. -
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (BMIR) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Samantha M.R. Kling
Quantitative Research Scientist, Primary Care and Population Health
Current Role at StanfordQuantitative Research Scientist in the Evaluation Sciences Unit (ESU)
-
Thomas Knightly
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioInterventional Psychiatry Fellow
-
Hanna Maria Knihtila
Affiliate, Department Funds
Fellow in Pediatrics - Allergy and Clinical ImmunologyBioHanna Knihtilä is an Allergy and Immunology Fellow at Stanford. She gained her MD in 2017 and PhD in 2018 from the University of Helsinki, Finland. She then completed her 2-year postdoctoral research fellowship at the Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, before joining Stanford for her residency and fellowship training.
